全文获取类型
收费全文 | 3268篇 |
免费 | 174篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 37篇 |
妇产科学 | 55篇 |
基础医学 | 375篇 |
口腔科学 | 67篇 |
临床医学 | 220篇 |
内科学 | 913篇 |
皮肤病学 | 87篇 |
神经病学 | 278篇 |
特种医学 | 120篇 |
外科学 | 666篇 |
综合类 | 14篇 |
一般理论 | 1篇 |
预防医学 | 46篇 |
眼科学 | 42篇 |
药学 | 158篇 |
中国医学 | 7篇 |
肿瘤学 | 358篇 |
出版年
2023年 | 20篇 |
2022年 | 40篇 |
2021年 | 80篇 |
2020年 | 43篇 |
2019年 | 49篇 |
2018年 | 71篇 |
2017年 | 55篇 |
2016年 | 70篇 |
2015年 | 77篇 |
2014年 | 112篇 |
2013年 | 117篇 |
2012年 | 212篇 |
2011年 | 216篇 |
2010年 | 97篇 |
2009年 | 99篇 |
2008年 | 177篇 |
2007年 | 196篇 |
2006年 | 185篇 |
2005年 | 206篇 |
2004年 | 208篇 |
2003年 | 171篇 |
2002年 | 179篇 |
2001年 | 62篇 |
2000年 | 43篇 |
1999年 | 53篇 |
1998年 | 39篇 |
1997年 | 16篇 |
1996年 | 24篇 |
1995年 | 25篇 |
1994年 | 25篇 |
1993年 | 11篇 |
1992年 | 33篇 |
1991年 | 38篇 |
1990年 | 39篇 |
1989年 | 38篇 |
1988年 | 32篇 |
1987年 | 41篇 |
1986年 | 38篇 |
1985年 | 44篇 |
1984年 | 23篇 |
1983年 | 19篇 |
1982年 | 16篇 |
1981年 | 10篇 |
1980年 | 9篇 |
1979年 | 21篇 |
1978年 | 14篇 |
1971年 | 7篇 |
1969年 | 7篇 |
1968年 | 8篇 |
1967年 | 10篇 |
排序方式: 共有3474条查询结果,搜索用时 0 毫秒
51.
Squamous Cell Carcinoma after Endoscopic Injection Sclerotherapy for Esophageal Varices 总被引:2,自引:0,他引:2
Norihiro Kokudo M.D. Kensho Sanjo M.D. Nobutaka Umekita M.D. Yasushi Harihara M.D. Yusuke Tada M.D. Yasuo Idezuki M.D. 《The American journal of gastroenterology》1990,85(7):861-864
We report two cases of squamous cell carcinoma of the esophagus following endoscopic injection sclerotherapy for esophageal varices. The interval between sclerotherapy and the development of carcinoma was 24 months in case 1 and 21 months in case 2. The sclerosant was 5% sodium morrhuate in case 1 (total dose, 10 ml) and 5% ethanolamine oleate in case 2 (45.5 ml). Although no recurrent variceal bleeding occurred after sclerotherapy, we could not perform any curative surgical treatment for esophageal cancer because of the advanced stage of the cancer and the severity of the accompanying liver dysfunction. It is difficult to determine the relationship between sclerotherapy and carcinoma; however, long-term surveillance is essential to avoid overlooking a neoplasm in the esophagus after endoscopic injection sclerotherapy. 相似文献
52.
Norihiro Nishida Tsukasa Kanchiku Yoshihiko Kato Yasuaki Imajo Yuichiro Yoshida Syunichi Kawano Toshihiko Taguchi 《The journal of spinal cord medicine》2015,38(5):593-598
Objective
Cervical myelopathy due to ossification of the posterior longitudinal ligament (OPLL) is induced by static factors, dynamic factors, or a combination of both. We used a three-dimensional finite element method (3D-FEM) to analyze the stress distributions in the cervical spinal cord under static compression, dynamic compression, or a combination of both in the context of OPLL.Methods
Experimental conditions were established for the 3D-FEM spinal cord, lamina, and hill-shaped OPLL. To simulate static compression of the spinal cord, anterior compression at 10, 20, and 30% of the anterior–posterior diameter of the spinal cord was applied by the OPLL. To simulate dynamic compression, the OPLL was rotated 5°, 10°, and 15° in the flexion direction. To simulate combined static and dynamic compression under 10 and 20% anterior static compression, the OPLL was rotated 5°, 10°, and 15° in the flexion direction.Results
The stress distribution in the spinal cord increased following static and dynamic compression by cervical OPLL. However, the stress distribution did not increase throughout the entire spinal cord. For combined static and dynamic compression, the stress distribution increased as the static compression increased, even for a mild range of motion (ROM).Conclusion
Symptoms may appear under static or dynamic compression only. However, under static compression, the stress distribution increases with the ROM of the responsible level and this makes it very likely that symptoms will worsen. We conclude that cervical OPLL myelopathy is induced by static factors, dynamic factors, and a combination of both. 相似文献53.
Acid and duodenogastroesophageal reflux after esophagectomy with gastric tube reconstruction 总被引:7,自引:0,他引:7
Yuasa N Sasaki E Ikeyama T Miyake H Nimura Y 《The American journal of gastroenterology》2005,100(5):1021-1027
OBJECTIVE: Patients who undergo esophagectomy with gastric tube reconstruction incur increased risk for acid reflux and duodenogastroesophageal reflux. Few postesophagectomy studies of gastroesophageal reflux disease have included simultaneous 24-h pH and bilirubin monitoring. The aim of this study is to evaluate acid reflux and duodenogastroesophageal reflux after esophagectomy with gastric tube reconstruction. METHODS: Reflux symptom evaluation, endoscopy, and simultaneous 24-h pH and bilirubin monitoring in the cervical esophagus were performed in 25 patients who underwent Ivor Lewis esophagectomy, intrathoracic esophagogastrostomy, and digital dilation of the pyloric ring as treatment for esophageal cancer. RESULTS: Reflux symptoms were severe, mild, and absent in 2, 7, and 16 patients, respectively. Reflux esophagitis and Barrett's esophagus was observed in 11 and 1 patients, respectively. Elevated acid reflux occurred in 7 patients (28%). Elevated duodenogastroesophageal reflux was recorded in 11 patients (44%). Reflux profile analysis identified three patterns: 4 subjects (16%) with both elevated acid reflux and duodenogastroesophageal reflux; 3 (12%) with only elevated acid reflux; and 7 (28%) with only elevated duodenogastroesophageal reflux. Of 7 patients with only elevated duodenogastroesophageal reflux, 4 developed reflux esophagitis. Although reflux symptoms did not correlate with endoscopic esophagitis, a significant correlation was observed between endoscopic esophagitis and acid reflux and/or duodenogastroesophageal reflux. CONCLUSIONS: Reflux symptoms represented a poor indication of esophagitis in patients with esophagectomy and gastric tube reconstruction. Simultaneous 24-h pH and bilirubin monitoring can help in identifying patients at high risk for reflux esophagitis, as well as indicating the cause of esophagitis. 相似文献
54.
Soh Nishimoto Kazutoshi Fujita Yohei Sotsuka Masato Kinoshita Toshihiro Fujiwara Kenichiro Kawai Masao Kakibuchi 《Journal of maxillofacial and oral surgery》2015,14(4):907-913
Objective
The aim of this study was to compare growth factor amount contained in platelet rich fibrin (PRF) and compare with that in platelet rich plasma (PRP), and in whole blood. And also to investigate distribution of growth factors and cellular components in PRF.Materials and Methods
PRF and PRP were obtained from the same sample of peripheral blood. Extraction of proteins were done with lysis buffer, accompanied by freeze and thaw procedures. Concentration of two representative growth factors in platelets: platelet derived growth factor (PDGF) and transforming growth factor beta (TGF-β), were measured with enzyme-linked immunosorbent assay (ELISA). PRF was cut into three parts: (top, middle and bottom), and growth factor concentration was measured respectively. Paraffin embedded section of PRF was observed with Giemsa stain. Immuno-histochemical analysis with anti-PDGF and anti-TGF-β antibodies was also conducted.Results
The growth factor levels in PRF was higher than in peripheral blood and comparable to those in PRP. Growth factor levels in bottom part of PRF was much higher than in top and middle part. Microscopically, platelets and mono-nucleated cells were concentrated just above the yellow–red interface. Poly-nucleated cells were concentrated below the interface.Conclusion
The growth factors were surely concentrated in PRF. This result can support basis of good clinical outcomes. For effective application of PRF, the knowledge that growth factors and cells are not equally distributed in PRF should be utilized. 相似文献55.
Norihiro Sato Kei Yabuki Kazunori Shibao Yasuhisa Mori Toshihisa Tamura Aiichiro Higure Koji Yamaguchi 《HPB : the official journal of the International Hepato Pancreato Biliary Association》2014,16(2):177-182
Background: A prolonged operative time is associated with adverse post-operative outcomes in laparoscopic surgery. Although a single-incision laparoscopic cholecystectomy (SILC) requires a longer operative time as compared with a conventional laparoscopic cholecystectomy, risk factors for a prolonged operative time in SILC remain unknown.Methods: A total of 20 clinical variables were retrospectively reviewed to identify factors for a prolonged operative time (longer than 3 h) in a total of 220 consecutive patients undergoing SILC.Results: The median operative time was 145 min (range, 55–435) and a prolonged operative time was required in 62 patients (28%). Independent factors that predict a prolonged operative time as identified through multivariate analysis were body mass index (BMI) (P = 0.009), acute cholecystitis (P < 0.001) and operator (resident or staff surgeon) (P < 0.001). Furthermore, a prolonged operative time was significantly associated with an increased amount of intra-operative blood loss (P < 0.001) and a prolonged stay after surgery (P < 0.001).Conclusions: These findings suggest that a higher BMI, acute cholecystitis and a resident as an operator significantly increase the duration of SILC procedures. 相似文献
56.
57.
58.
Nunobe S Kiyokawa T Hatao F Wada I Shimizu N Nomura S Mise Y Sugawara Y Kokudo N Seto Y 《Hepato-gastroenterology》2012,59(113):307-309
Systemic chemotherapy is the treatment recommended for prolonged survival in cases of metastatic gastric cancer. There have been a number of clinical reports of surgical resection of liver metastasis in selected patients with gastric cancer. Here, we report on a case of treatment of far advanced gastric cancer with synchronous multiple liver metastases with prompt S-1 in combination with fractional cisplatin sandwiched between twostage surgery. Metastases including peritoneal dissemination and extensive lymph node involvement were absent so it was feasible to completely remove all of the macroscopic liver metastases. Each step of the chemotherapy progressed satisfactorily and histological examination after the hepatectomy yielded a pathologically complete response of liver metastases from the gastric cancer. This strategy provides a promising treatment for far advanced gastric cancer with a limited number of synchronous liver metastases. The referral to surgical oncology is a crucial step for the documentation of pathological complete response. 相似文献
59.
P. Romanelli R. Nishimoto R. Suarez R. Decia D. Abreu M. Machado C. Arroyo H. Campolo E. Campos A.S. Carlos M. Tobias-Machado 《Actas urologicas espa?olas》2013,37(5):305-310
IntroductionWe evaluated the reproducibility of video endoscopic inguinal lymphadenectomy (VEIL) and we report our initial experience in the treatment of penile cancer with palpable inguinal lymph nodes.Material and methodsFrom July 2006 to November 2010 were conducted 33 VEIL in 20 patients as complementary treatment for penile cancer in two referral hospitals in Latin America. We analyzed the epidemiological and clinical characteristics of patients and surgical and oncologic outcomes.ResultsFifty-five percent of the patients included were clinical stage N0 and 45% were N +. Thirteen patients underwent bilateral VEIL and the remaining seven underwent VEIL unilateral and conventional open surgery in the contralateral limb. The average operative time for VEIL was 119 minutes and mean resected lymph nodes was 8 per lymphadenectomy. The overall complication rate was 33.2%. No patient had skin necrosis. The lymphatic complication rate was 27.2%. Of the 6 cases in which the saphenous vein was preserved (18.2%) there were no lymphatic complications (P = ,2). The overall survival rate was 80% and cancer-specific survival was 90%. Mean follow-up was 20 months.ConclusionsVEIL in the adjunctive treatment of penile cancer is safe, reproducible and may be an alternative to conventional lymphadenectomy. Patients with palpable lymphadenopathy also may benefit from this technique. Oncological results seem to be adequate however require longer follow-up to be confirmed. 相似文献
60.
Kato N 《Hypertension research》2012,35(6):574-581
Recently, large-scale meta-analyses of genome-wide association (GWA) studies have identified a number of loci significantly associated with systolic and/or diastolic blood pressure (BP). Most of the GWA studies reported to date were conducted in populations of European descent. Given the appreciable ethnic differences in clinical presentation of hypertension, studies in non-European populations allow us to assess the relevance of the findings in Europeans to other ethnic groups and to potentially discover novel variants. Before the GWA scan era, the presence of racial or ethnic differences has been widely recognized for response to antihypertensive therapies, salt sensitivity and impact of obesity on developing hypertension. Despite a limited number of genetic loci that have been proven to show substantial ethnic differences, we can assume four possible genetic mechanisms--(1) absence of target variants in other ethnic groups; (2) presence of allelic heterogeneity; (3) difference in linkage disequilibrium structure; and (4) gene-gene and gene-environment interactions. Considering such a number of potential sources of heterogeneity, we should be cautious about claiming the presence of genuine ethnic differences in genetic susceptibility to BP-related traits or hypertension. Approximately a quarter of BP-associated loci that have been reported in four meta-analyses of GWA studies (i.e., 8 out of 34 loci) appear to be common across three ethnic groups--Europeans, east Asians and south Asians. 'Transethnic' BP meta-analysis will be useful not only for revealing novel susceptibility loci and pathophysiological pathways but also for facilitating the fine mapping of common causal variants. 相似文献